The use of rituximab in the treatment of malignant and nonmalignant plasma cell disorders.
about
Waldenström macroglobulinemiaSLE - Rituximab in lupusPharmacotherapy for uveitis: current management and emerging therapy.Treating human autoimmune disease by depleting B cellsPharmacotherapy of scleritis: current paradigms and future directions.Application of a novel inhibitor of human CD59 for the enhancement of complement-dependent cytolysis on cancer cells.A SCID-hu in vivo model of human Waldenström macroglobulinemia.An anti-GD2 monoclonal antibody enhances apoptotic effects of anti-cancer drugs against small cell lung cancer cells via JNK (c-Jun terminal kinase) activation.
P2860
Q24634076-865FF0E9-879B-4A7F-A1C4-540CA010BB2AQ24804739-1C34ABD6-7B66-4F28-B28E-559366647B3AQ34274075-1BFA6BFD-E140-4E4C-BC1F-F0B6C0E5BF45Q34848963-462AC1AD-BFC7-45BE-B0EA-0AB7B5969CBFQ37466204-1DCA9459-4E52-4180-86BE-233A6C55776CQ39024745-26BF9F2C-D0E4-4D29-91E0-C503D23F25F9Q42742542-9A1E4250-AB22-49F3-972D-DD8884630A54Q44083589-D15DD27D-955D-4236-906C-9EE0375072E1
P2860
The use of rituximab in the treatment of malignant and nonmalignant plasma cell disorders.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
The use of rituximab in the tr ...... lignant plasma cell disorders.
@ast
The use of rituximab in the tr ...... lignant plasma cell disorders.
@en
The use of rituximab in the tr ...... lignant plasma cell disorders.
@nl
type
label
The use of rituximab in the tr ...... lignant plasma cell disorders.
@ast
The use of rituximab in the tr ...... lignant plasma cell disorders.
@en
The use of rituximab in the tr ...... lignant plasma cell disorders.
@nl
prefLabel
The use of rituximab in the tr ...... lignant plasma cell disorders.
@ast
The use of rituximab in the tr ...... lignant plasma cell disorders.
@en
The use of rituximab in the tr ...... lignant plasma cell disorders.
@nl
P1433
P1476
The use of rituximab in the tr ...... lignant plasma cell disorders.
@en
P2093
P433
6 Suppl 12
P577
2000-12-01T00:00:00Z